Oncology & Cancer

Boosting T cells improves survival in mice with glioblastoma

Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10 percent ...

Oncology & Cancer

DNA nanotubes deliver therapeutics to glioblastoma tumors

Glioblastoma is widely considered the most aggressive brain cancer. Even with treatment, patient survival rates are low, with most living an average of 15–18 months after diagnosis. Because of the highly diverse characteristics ...

Oncology & Cancer

Stress pushes brain cancer cells to adapt, shows study

Glioblastoma multiformes is a potentially devastating brain tumor. Now, a collaboration between UConn Health and The Jackson Laboratory (JAX) is discovering what makes them so adaptable and dangerous and sometimes able to ...

page 10 from 39